ODI Pharma AB (publ) (NGM:ODI)
Sweden · Delayed Price · Currency is SEK 3.440
-0.100 (-2.82%)
At close: Feb 26, 2026
ODI Pharma AB Market Cap
ODI Pharma AB has a market cap or net worth of 64.89 million as of February 26, 2026. Its market cap has increased by 47.73% in one year.
Market Cap
64.89M
Enterprise Value
62.00M
Revenue
8.96M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.44
Market Cap Chart
Since January 27, 2020, ODI Pharma AB's market cap has decreased from 129.98M to 64.89M, a decrease of -50.08%. That is a compound annual growth rate of -10.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 64.89M | -18.06% |
| Dec 30, 2025 | 79.19M | 124.13% |
| Dec 30, 2024 | 35.33M | -53.57% |
| Dec 29, 2023 | 76.10M | 27.88% |
| Dec 30, 2022 | 59.51M | -20.53% |
| Dec 30, 2021 | 74.88M | 1.44% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 27, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Coegin Pharma AB | 103.24M |
| Spotlight Group AB | 98.81M |
| Ramlösa shipping AB | 82.04M |
| Mediacle Group AB | 76.92M |
| Transfer Group AB | 66.84M |
| Lohilo Foods AB | 58.39M |
| NGS Group AB | 57.81M |
| Katalysen Ventures AB | 55.85M |